HEPATOPROTECTIVE ACTIVITY OF CHRYSOPHYLLUM ALBIDUM AGAINST CARBON TETRACHLORIDE INDUCED HEPATIC DAMAGE IN RATS

The leaf extract of Chrysophyllum albidum was studied for hepatoprotective activity against rats with induced liver damage by carbon tetrachloride (CCl4). The rats were divided into five groups of eight rats per group. Animals of group A served as normal and were given only vehicle (distilled water) for 7 days. Animals of group B (positive control) were administered with vehicle on the first four days, and with the vehicle and CCl4 on the fifth, sixth and seventh day. The animals of groups C, D and E were respectively administered with 500, 1000 and 1500 mg/kg of extract & distilled water for the first four days, and with distilled water, extract and CCl4 on the last three days. Animals were subsequently anaesthetized and blood samples were collected for alanine amino transferase (ALT), aspartate amino transferase (AST), alkaline phosphatase (ALP), total bilirubin, total protein and albumin assays; liver organ was isolated and processed for histopathological studies. The results showed that the levels of AST, ALT, ALP and total bilirubin were significantly higher in rats treated with CCl4 indicating liver injury, while these parameters were reduced significantly (p < 0.05) after treatment of rats with the extract. The hepatoprotective activity of C. albidum was also supported by histopathological studies of liver tissue. The liver tissue of rats in the group treated with CCl4 showed marked centrilobular fatty degeneration and necrosis while the groups treated with plant extract showed signs of protection against this toxicant as evidenced by the absence of necrosis

Antioxidant activities of the leaves of Chrysophyllum Albidum G.

Chrysophyllum albidum G. is a tropical plant and commonly found in Nigeria. It belongs to the sapotaceae family and used in folklore in the treatment of yellow fever, malaria, diarrhea, vaginal and dermatological infections. The study was aimed at investigating the antioxidant properties of this plant by employing the in vitro and in vivo experimental models. The effect of DPPH free radical scavenging activity on the fractions of petroleum ether, ethanol, butanol, ethylacetate, and water of C. albidum was determined. The ethyl acetate fraction was purified in colunm chromatography to obtain myricetin rhamnoside. Structure elucidation was done by NMR and mass spectroscopic techniques. Furthermore, ethanol extract was administered to five groups of eight rats per group. The animals in the normal group were administered with vehicle alone for 7 days. The positive control animals were given vehicle on the first four days, and with the vehicle and hepatotoxin (CCl4) on the fifth, sixth and seventh day. The animals in the treatment category were respectively administered with 500, 1000 and 1500 mg/kg b.w. of extract &amp; distilled water for the first four days, and with distilled water, extract and CCl4 on the last three days. Animals were subsequently anaesthetized and blood samples were collected for catalase (CAT), malondialdehyde (MDA), reduced gluthathione (GSH) and superoxide dismutase (SOD) assays. The petroleum ether fraction showed the least antiradical activity (4057.5 ± 809.6 g/kg) while ethyl ether exhibited the highest activity (414.4 ± 92.0 g/kg). Myricetin rhamnoside also exhibited an excellent radical scavenging activity (314.1 ± 60.2) which was comparable to the positive control. Result from animal study showed that C. albidum exhibited significant (p &lt; 0.05) differences on the activity of CAT, MDA and GSH. The plant could therefore be employed as sources of natural antioxidant boosters and for the treatment of some oxidative stress disorders in which free radicals are implicated

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population